共 177 条
[1]
Amin D(1992)Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis J Lipid Res 33 1657-1663
[2]
Cornell SA(2001)Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts Bone 28 465-473
[3]
Gustafson SK(2002)Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases J Clin Pharmacol 42 1228-1236
[4]
Needle SJ(2003)New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects Br J Cancer 88 1631-1640
[5]
Ullrich JW(2001)Structure-activity relationships for inhibition of farnesyl diphosphate synthase J Pharmacol Exp Ther 296 235-242
[6]
Bilder GE(2009) and inhibition of bone resorption Cancer Research 69 44-691
[7]
Perrone MH(2009) by nitrogen-containing bisphosphonates N Engl J Med 360 679-1271
[8]
Benford HL(2005)The effect of zoledronic acid on aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36 months follow-up of ZO-FAST J Natl Cancer Inst 97 1262-751
[9]
McGowan NW(1994)Endocrine therapy plus zoledronic acid in premenopausal breast cancer J Bone Miner Res 9 745-1134
[10]
Helfrich MH(2001)Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17 Br J Cancer 84 1126-S22